Meridian Bioscience Comments on Recent FDA Posting Related to Magellan Diagnostics June 6, 2017 Read More
Meridian Bioscience Comments on FDA Matter Involving its Subsidiary, Magellan Diagnostics May 17, 2017 Read More
Meridian Bioscience Engages Korn Ferry to Conduct CEO Search as John A. Kraeutler Announces Plans to Retire May 10, 2017 Read More
Magellan Diagnostics (Meridian Bioscience, Inc., NASDAQ: VIVO) Launches National Education Initiative on Risks of Lead Exposure for Pregnant Women May 9, 2017 Read More
Meridian Continues Its Fight Against Tropical Diseases by Introducing the Most Comprehensive Menu of Antigens and Antibodies for Diagnostic Applications May 4, 2017 Read More
Meridian Bioscience Reports Second Quarter 2017 Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2017 Guidance April 27, 2017 Read More
Prosedur Pengujian Baru Berpotensi Besar Menjadi Alat Penting dalam Upaya Global untuk Memberantas Malaria April 24, 2017 Read More
Prosedur Ujian Baru Memegang Janji Sebagai Alat Kritikal dalam Usaha Global untuk Menghapuskan Malaria April 24, 2017 Read More
ขั้นตอนการทดสอบใหม่คาดว่าจะเป็นเครื่องมือสำคัญในความพยายามของโลกเพื่อขจัดโรคมาลาเรีย April 24, 2017 Read More
